Isoniazid MIC and KatG Gene Mutations among Mycobacterium tuberculosis Isolates in Northwest of Iran
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 14، شماره: 6
سال انتشار: 1390
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 150
فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-14-6_007
تاریخ نمایه سازی: 3 آبان 1400
چکیده مقاله:
Objective(s) Isoniazid (INH) is one of the main first line drugs used in treatment of tuberculosis and development of resistance against this compound can result in serious problems in treatment procedures. Resistance to INH is mediated mainly by mutation in KatG gene that is coded for the catalase enzyme. The proportional method for detection of INH-resistance is time consuming due to the slow growth rate of Mycobacterium tuberculosis. In this study, we used PCR-RFLP approach for screening of common mutations in KatG gene for detection of INH resistance, and compared the results to minimal inhibitory concentration (MIC) in M. tuberculosis isolates. Materials and Methods Fifty M. tuberculosis isolates were subjected to study of which, ۲۵ strains were INH-resistant and ۲۵ strains were INH-sensitive. Results Of ۲۵ INH-resistant strains, the mutation was identified in ۵۶% and ۲۰% in the KatG۳۱۵ and KatG۴۶۳ loci, respectively. In ۲۴% of INH-resistant strains, no mutation was observed in the studied loci. INH MIC was <۰.۲ pg/ml in all sensitive strains whereas among ۲۵ INH -resistant isolates, INH MIC was higer than ۰.۲ pg/ml ranged from ۰.۲ to ۳.۲ pg/ml. Conclusion Our findings revealed that PCR-RFLP is capable to identify INH-resistance in more than ۷۶% of INH- resistant M. tuberculosis strains, and could be used for rapid identification of INH resistance. High levels of INH MIC were observed in the strains which had mutation in the KatG gene in position ۳۱۵.
کلیدواژه ها:
نویسندگان
Seed Reza Moaddab
Tuberculosis and Lung Research Centre and Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran
Safar Farajnia
Biotechnology Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran
Davood Kardan
Infectious and Tropical Disease Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran
Sajad Zamanlou
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Mohammad Yousef Alikhani
Microbiology department, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :